Using a Metabotype Framework to Deliver Personalized Nutrition Improves Dietary Quality and Metabolic Health Parameters: A 12-Week Randomized Controlled Trial

被引:7
|
作者
Hillesheim, Elaine [1 ,2 ]
Yin, Xiaofei [1 ,2 ]
Sundaramoorthy, Geetha Priya [1 ,2 ]
Brennan, Lorraine [1 ,2 ]
机构
[1] Univ Coll Dublin, UCD Inst Food & Hlth, UCD Sch Agr & Food Sci, Dublin, Ireland
[2] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, Dublin, Ireland
基金
欧洲研究理事会;
关键词
biomarkers; metabolic subgroups; metabolomics; metabotypes; personalized nutrition; MEDITERRANEAN DIET; CARDIOVASCULAR-DISEASE; PLASMA-CONCENTRATIONS; RISK; ASSOCIATION; ADHERENCE; MEN; OUTCOMES; PREDICT; WEIGHT;
D O I
10.1002/mnfr.202200620
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
ScopeEffective strategies for tailoring dietary advice to individuals are urgently needed. The effectiveness of personalized nutrition advice delivered using a metabotype framework in improving dietary quality and metabolic health biomarkers compared to population-level advice is investigated. Materials and resultsA 12-week parallel randomized controlled trial is performed with 107 healthy adults. Individuals in the personalized group are classified into metabotypes using four markers (triacylglycerol, high-density lipoprotein [HDL]-cholesterol, total cholesterol [TC], and glucose) and received dietary advice from decision tree algorithms containing metabotypes characteristics and individual traits. Individuals in the control group received generic dietary advice based on national guidelines. The personalized approach results in higher dietary quality assessed by the Alternate Mediterranean Diet Score (effect size [95% confidence interval, CI], 0.77 [0.07, 1.48], 12% versus 3% increase) and significantly lower concentrations of triacylglycerol (-0.17 [-0.28, -0.06] log10 mmol L-1), TC (-0.42 [-0.74, -0.10] mmol L-1), low-density lipoprotein (LDL)-cholesterol (-0.34, [-0.60, -0.09] mmol L-1), and lower triacylglycerol-glucose index (-0.40, [-0.67, -0.13]). Sixteen phosphatidylcholines and six lysophosphatidylcholines, predominately with chain lengths of 30-36 carbons, are lower in the personalized group. ConclusionsPersonalized nutrition advice delivered using the metabotype framework is effective to improve dietary quality, which could result in reduced CVD risk, and metabolic heath biomarkers.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Personalized nutrition intervention improves nutritional status and quality of life of colorectal cancer survivors in the community: A randomized controlled trial
    Wang, Xuan
    Zeng, Huiling
    Li, Li
    Fang, Zhen
    Xu, Lihua
    Shi, Weijun
    Li, Jianxin
    Qian, Junqiu
    Tan, Xiaoqing
    Li, Jiezhen
    Qian, Ying
    Xie, Li
    NUTRITION, 2022, 103-104
  • [22] Assessment of gait parameters and physical function in patients with advanced cancer participating in a 12-week exercise and nutrition programme: A controlled clinical trial
    Schink, Kristin
    Gassner, Heiko
    Reljic, Dejan
    Herrmann, Hans J.
    Kemmler, Wolfgang
    Schwappacher, Raphaela
    Meyer, Julia
    Eskofier, Bjoern M.
    Winkler, Juergen
    Neurath, Markus F.
    Klucken, Jochen
    Zopf, Yurdaguel
    EUROPEAN JOURNAL OF CANCER CARE, 2020, 29 (02)
  • [23] Effects of a 12-week digital training equipment program on cognitive function and mental health in older women: a randomized controlled trial
    Lee, Byung-Sun
    Choi, Bong Du
    Park, Ho Sung
    Seo, Chae Won
    Kim, Kyung-Ae
    DIGITAL HEALTH, 2025, 11
  • [24] Effects of a 12-week endurance training on the stress-health relationship and the physiological stress response in men: A randomized controlled trial
    Klaperski, Sandra
    Fuchs, Reinhard
    JOURNAL OF SPORT & EXERCISE PSYCHOLOGY, 2013, 35 : S95 - S95
  • [25] Effects of omega-3 fatty acids on metabolic syndrome in patients with schizophrenia: a 12-week randomized placebo-controlled trial
    Xu, Feikang
    Fan, Weixing
    Wang, Weiping
    Tang, Wei
    Yang, Fuyin
    Zhang, Yi
    Cai, Jun
    Song, Lisheng
    Zhang, Chen
    PSYCHOPHARMACOLOGY, 2019, 236 (04) : 1273 - 1279
  • [26] Effects of omega-3 fatty acids on metabolic syndrome in patients with schizophrenia: a 12-week randomized placebo-controlled trial
    Feikang Xu
    Weixing Fan
    Weiping Wang
    Wei Tang
    Fuyin Yang
    Yi Zhang
    Jun Cai
    Lisheng Song
    Chen Zhang
    Psychopharmacology, 2019, 236 : 1273 - 1279
  • [27] Eriobotrya japonica Improves Cognitive Function in Healthy Adolescents: A 12-week, Randomized Double-blind, Placebo-controlled Clinical Trial
    Choi, Eun-Kyung
    Ko, Myoung-Hwan
    Park, Soo-Hyun
    Ha, Ki-Chan
    Baek, Hyang-Im
    Kim, Yong-Jae
    Lee, Joon-Yeol
    Chae, Han-Jung
    Cho, Kyu-Park
    Won, Yu Hui
    Chae, Soo-Wan
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2016, 12 (04) : 370 - 378
  • [28] A 12-week, randomised, controlled trial to examine the acceptability of the Korean diet and its effectiveness on weight and metabolic parameters in an Australian overweight and obese population
    Fuller, Nicholas R.
    Lau, Namson S.
    Denyer, Gareth
    Simpson, Annie E.
    Gerofi, James
    Wu, Min
    Holmes, Andrew
    Markovic, Tania P.
    Kang, Jae-Heon
    Caterson, Ian D.
    OBESITY RESEARCH & CLINICAL PRACTICE, 2012, 6 (01) : E71 - E83
  • [29] Effects of a 12-week home-based exercise program on quality of life, psychological health, and the level of physical activity in colorectal cancer survivors: a randomized controlled trial
    Kim, Ji Young
    Lee, Mi Kyung
    Lee, Dong Hoon
    Kang, Dong Woo
    Min, Ji Hee
    Lee, Ji Won
    Chu, Sang Hui
    Cho, Min Su
    Kim, Nam Kyu
    Jeon, Justin Y.
    SUPPORTIVE CARE IN CANCER, 2019, 27 (08) : 2933 - 2940
  • [30] Effects of a 12-week home-based exercise program on quality of life, psychological health, and the level of physical activity in colorectal cancer survivors: a randomized controlled trial
    Ji Young Kim
    Mi Kyung Lee
    Dong Hoon Lee
    Dong Woo Kang
    Ji Hee Min
    Ji Won Lee
    Sang Hui Chu
    Min Su Cho
    Nam Kyu Kim
    Justin Y. Jeon
    Supportive Care in Cancer, 2019, 27 : 2933 - 2940